The largest database of trusted experimental protocols

Muramyl dipeptide

Manufactured by Merck Group
Sourced in United States

Muramyl dipeptide is a synthetic compound that mimics a component of bacterial cell walls. It is a biologically active molecule that can stimulate the immune system. This lab equipment product is used in research applications to investigate immune system responses and potential therapeutic applications.

Automatically generated - may contain errors

3 protocols using muramyl dipeptide

1

Inflammation Signaling Pathway Analysis in Murine CECs

Check if the same lab product or an alternative is used in the 5 most similar protocols
An ELISA assay (Cell Signaling Technology 7276) containing members of key inflammatory signaling pathways, including NF-κB, SAPK/JNK, p38 MAPK, and STAT3, was used. Primary murine CECs were isolated as previously described (24 (link)) and normalized to 1.5 × 106/mL by hemocytometer and cultured for 4 h in the presence or absence of tomato extracts. Aqueous tomato extracts were added to a 2% final concentration (volume/volume ratio). The cultures were then stimulated with bacterial peptides (MAMPs); 1 µg/mL of peptidoglycan (S. aureus, Sigma), 1 µg/mL of muramyl dipeptide (Bachem), and 1 µg/mL of lipopolysaccharide (S. typhosa, Sigma) for 30 min, except the uninduced control. The assay was replicated three times. Stimulated cells were then lysed immediately following the protocol recommended by the manufacture. Protein concentrations were checked by Lowry protein assay (Bio Rad 500-0120), and samples were normalized to 700 µg/mL. Cell lysates were diluted 1:1 with sample dilutant (Cell Signaling Technology) and 200 µL of diluted lysates were used per well.
To determine if the ELISA results were significantly different, single-factor ANOVA analysis was performed.
+ Open protocol
+ Expand
2

SERPINB1 Regulates NLRP3 Inflammasome Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human IL-1β ELISA Set II, human TNF ELISA Set, human IL-6 ELISA Set and mouse IL-1β ELISA Set (BD OptEIA). THP1 cells (1 × 106 cells per well in a six-well plate) were transduced with scramble or shSERPINB1 lentivirus for 48 h and primed with 1 μg ml−1 LPS (0127:B8, Sigma) for 12 h. For NLRP3 inflammasome activation, THP1 cells were differentiated with 100 ng ml−1 phorbol 12-myristate 13-acetate (Calbiochem) for 72 h, transduced by scramble or shSERPINB1 lentivirus for 48 h, and primed with LPS (0.5–1 μg ml−1) overnight. Cells were washed by PBS and stimulated with control media for 3 h, 2 μM nigericin (Sigma) for 3 h, 10 μg ml−1 muramyl dipeptide (Sigma) for 6 h, 5 mM ATP (Sigma) for 1 h, 2.5 μg ml−1 flagellin (Invivogen) for 6 h, or 1 μg ml−1 poly(dA:dT)/LyoVec (Invivogen) for 6 h. For caspase inhibitor treatment, THP1 cells were transduced with scramble or shSERPINB1 lentivirus for 48 h, treated with indicated caspase inhibitors (20 μM) 1 h before LPS (1 μg ml−1, 12 h) priming. Caspase inhibitors include z-YVAD-FMK (Santa Cruz), z-LEVD-FMK (BioVision), z-WEHD-FMK (BioVision), z-DEVD-FMK (Santa Cruz) and z-VAD-FMK (Santa Cruz).
+ Open protocol
+ Expand
3

Heat-killing bacteria for zebrafish priming

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the preparation of heat-killed bacteria, L. monocytogenes (10403S), E. coli (ATCC 25922), S. aureus (ATCC 29213), S. typhimurium (ATCC 14028) and S. iniae (ATCC 29178) were inoculated from glycerol stocks or blood agar plates and cultured in brain heart broth (BHB) (Sigma-Aldrich, MO, USA) at 37°C until the OD600 nm reached 0.9-1.0. Bacterial suspensions were plated on LB agar plates to verify bacterial concentrations. To heat-kill bacteria, the bacterial suspensions were autoclaved in BHB at 120°C for 20 min and the sterility was confirmed by plating on LB plates after autoclaving. Injection doses of heat-killed bacteria for adult zebrafish were 0.5×107-1×107 cfu. Injection doses for other priming agents were 13.5 µg/fish for LPS (Sigma-Aldrich, MO, USA), paclitaxel (Sigma-Aldrich, MO, USA) and zymosan (Sigma-Aldrich, MO, USA), and 4.5 µg/fish for muramyl-dipeptide (Sigma-Aldrich, MO, USA). Priming i.p. injections (5 µl) were injected with an Omnican 100 30 G insulin needle (Braun, Melsungen, Germany) under 0.02% 3-aminobenzoic acid ethyl ester (pH 7.0) anesthesia.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!